integrating palbociclib into the treatment of breast cancer
Published 9 years ago • 927 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
![palbociclib in the management of breast cancer - video abstract [46725]](https://i.ytimg.com/vi/BcMyEstXUM8/mqdefault.jpg)
1:26
palbociclib in the management of breast cancer - video abstract [46725]
-
13:22
palbociclib and breast cancer
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
6:47
palbociclib: single-agent or in combination for the treatment of breast cancer
-
12:43
palbociclib in breast cancer
-
5:43
cdk 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer
-
2:55
dr. tripathy on the development of palbociclib in breast cancer
-
1:41
dr. richard finn describes the phase iii trial of palbociclib for breast cancer
-
1:34
dr. richard finn on the future of palbociclib in breast cancer
-
2:04
dr. richard finn discusses palbociclib for patients with advanced breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
![palbociclib combinations on treatment of advanced breast cancer – video abstract [id 77033]](https://i.ytimg.com/vi/PmoHtf8pc5M/mqdefault.jpg)
13:24
palbociclib combinations on treatment of advanced breast cancer – video abstract [id 77033]
-
8:25
paloma-1 study of palbociclib in er , her2-, breast cancer
-
3:34
2016 acs heroes of chemistry: pfizer – ibrance® for the treatment of metastatic breast cancer
-
1:00
dr. borgen on the evolution of breast cancer treatment
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
1:00
dr. ruddy on the management of cns metastases in her2 breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update